Clinical Trial Update: Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This document reports on a Phase 1/2 clinical trial evaluating the combination of Imatinib Mesylate and Cytarabine in newly diagnosed chronic myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Imatinib mesylate (Imatinib)

Snippet

Sponsor: Commissie Voor Klinisch Toegepast Onderzoek | Conditions: Leukemia | Phase 1, Phase 2 | Status: UNKNOWN